Create a free account
(iPad, iPhone, Android and Web)
  • The DoseMe Experience

    "These programmes [iPad and web-interface] provide easy to use dosing support for these difficult to dose medications... We have found the DoseMe software very straightforward for doctors to use."

    – Prof. Jenny Martin MBChB, MA, FRACP, PhD
    Clinical Pharmacologist, PAH; Head of PAH Clinical School, UQ

  • Independent study finds DoseMe most accurate

    DoseMe has been evaluated in an independent study for tobramycin dosing in children with cystic fibrosis. It is the most accurate dosing method available!

    Hennig et al. 2014, PAGANZ

  • Dose-individualisation and chemotherapy

    Independent studies have shown that personalised dosing:

1   improve outcomes 2   reduce adverse events 3   reduce costs

What is DoseMe?

DoseMe is easy-to-use software that allows clinicians to dose a patient based upon that patient's individual ability to absorb, process, and clear a drug. Using simple patient information, such as height, weight, and gender, DoseMe can accurately calculate dosage to suit an individual patient.

While this is already significantly more accurate than standard clinical practice4, DoseMe then additionally incorporates patient-specific laboratory results — and continues to learn over time. By doing so, DoseMe provides true personalised medicine — and significantly improved dosing accuracy and patient outcomes.

DoseMe is designed to be used by clinicians and healthcare practitioners to improve patient care by improving dosing. DoseMe is available for use by clinicians at the bedside via portable smart-devices, at their desk via rich web-app, as well as being able to be integrated into patient management software. DoseMe supports use by anyone from a single clinician to across an entire hospital.

For More Information…

DoseMe has two introductory brochures: one introducing personalised medicine, with case studies of DoseMe in action; and a second introducing the cloud-based technology behind DoseMe.

We also have frequently asked questions and further scientific information. The FAQ includes information on the regulatory standards that DoseMe complies with, as well as information on supported drugs, while the scientific information contains more information about DoseMe and the clinical impact of individualised dosing.

If your question isn't answered here, please contact us.

DoseMe is Proven

DoseMe has been shown in an independent study to be the most accurate dosing method tested. In this study, several dosing methods (and software) were evaluated using patient data from children with cystic fibrosis (at the Royal Childrens' Hospital, Brisbane).

The core concept behind DoseMe (Bayesian dosing) is extremely well supported in the scientific literature, with published clinical trials from 19691 onwards showing many benefits. In summary:

Patient benefits:


For more detail, we have more of the science here, with literature references.

News and Updates

Jul 15: DoseMe is in The Australian today. Read about how Start-up DoseMe adds a measure of medical safety.

Jul 10: DoseMe has released an introductory brochure on personalised medicine, highlighting the importance of individualised dosing and featuring two case studies using DoseMe.

Jun 13: DoseMe has won the start-up category in the 2014 Queensland iAwards. To quote: "This award recognises the most outstanding ICT company that is still in the start up phase of development." We look forward to the national round!

Jun 12: DoseMe pricing announced at PAGE. Compare DoseMe Premium, Team, Enterprise and Corporate.

Jun 11: We're at the PAGE conference in Spain: Come and drop by our booth and try out personalised dosing!

Mar 14: Our Technical Director was invited to talk at the Brisbane DevOps group: "DevOps in a Regulated World: Ansible, AWS & Jenkins"

Feb 14: DoseMe has been shown in an independent study to be the most accurate dosing method for tobramycin in children with cystic fibrosis.

Oct 13: DoseMe has been updated with native iPhone support. DoseMe now supports iPhone, iPad, Web and mobile web for other tablets and phones.

Jun 13: DoseMe attended PAGE2013, where we presented a scientific poster on using DoseMe for warfarin dose-adjustment.

  1. Sheiner, L. B. Computer-aided long-term anticoagulation therapy. Computers and Biomedical Research, 1969:2, 507-518
  2. Evans, WE et al. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. New England Journal of Medicine, 1998:338, 499-505
  3. Relling, MV et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol, 1994:12, 1667-1672
  4. Matthews, I et al. Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. British Journal of Clinical Pharmacology, 2004:58, 8-19
  5. van Lent-Evers, NA et al. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis. Therapeutic drug monitoring, 1999:21, 63-73
  6. Barras, M et al. Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 2011:41
  7. Schumacher GE and Barr JT. Economic and outcome issues for therapeutic drug monitoring in medicine. Ther Drug Monit. 1998 Oct;20(5):539-42.